Showing all news

Georg-August-University Göttingen, Universitätsmedizin and MRC Technology collaborate to develop new therapy for neurodegenerative diseases

Georg-August-University Göttingen (UMG) and MRC Technology (MRCT) have signed a collaboration agreement for the development of a novel therapy for neurodegenerative diseases based on an antibody that targets particular forms of amyloid beta peptides, amyloid beta 4-x. The aim is to develop a new antibody therapy for Alzheimer’s Disease (AD).

28 July 2015

Keytruda: A first-in-class cancer therapy

BIA’s report, Celebrating UK bioscience, features UK bioscience successes. It incldes Keytruda, a new generation drug which uses the body’s immune system to fight cancer. It features MRC Technology’s role humanising the antibody. Read the article.  

27 July 2015

Poster at Biophysics in Drug Discovery 2015

Coombs, P., Ansell, K., Whalley, D., Jones, H., Mpamhanga, C., Osborne, S., Large, J., Smiljanic-Hurley, E.,  Harding, D., Visser, N., Pepper, D., Taylor, D. (2015), Fragment-based discovery and characterisation of inhibitors of the de novo purine biosynthetic  enzyme PAICS. In  Biophysics in Drug Discovery, Medicinal Chemistry, 9-12 June 2015, Strasbourg, France

23 June 2015

Poster prize for presentation at Chemistry in Health Conference

Ela Smiljanic-Hurley’s poster presentation at the Chemistry in Health Conference 2015, held on 26 May at the Royal Society of Chemistry, was voted best poster by conference delegates. View the poster here. Ela is a scientist in the Chemistry department at MRC Technology.

27 May 2015

Poster presented at Chemistry in Health 2015 conference

Smiljanic-Hurley, E., Large, J.M., Merritt, A.T., Osborne, S.A., Ansell, K.H., Kettleborough, C.A., Whalley, D., Khan, S., Tickle, D.C., Bowyer, P., Stewart, L. Barker, D.A. (2015). Design and synthesis of imidazopyridine inhibitors of PfPKG, a malarial kinase. In Chemistry in Health 2015, 26 May 2015, London UK.

27 May 2015

Poster presented at Essential Protein Engineering Summit 2015

Patel, S., Fernandes, C., Camelo, A., Brown, R., Bartlett, N.W., Johnson, S.L., Barlow, J., McKenzie, A., Matthews, D., (2015). A humanized anti-IL-17BR monoclonal antibody with wide therapeutic potential in allergic asthma, ulcerative colitis, pulmonary fibrosis and pancreatic cancer. In PEGS (Boston) Conference, 4-8 May 2015, Boston USA

19 May 2015

Dementia care digital platform launched by partnership including MRC Technology

Brain health company IXICO launched a digital platform, Project Cygnus, to support patients with the diseases that cause dementia. IXICO is the lead partner in the project, working alongside MRC Technology, The Northern Health Science Alliance Network (NHSA) and several NHS Trusts in the North of England. The project is part-funded by Innovate UK (formerly the Technology Strategy Board).

30 April 2015
Showing all news